Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
Presant
C A
CA
Wilshire Oncology Medical Group, Los Angeles, California.
Wiseman
C
C
Gala
K
K
Kennedy
P
P
Bouzaglou
A
A
Blayney
D
D
Schindler
J
J
Rigas
M
M
Melville
J
J
Dolan
J
J
D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008787:Metoclopramide / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced* / Q000188:drug therapy
D008787:Metoclopramide; D002945:Cisplatin